Drug
Izencitinib clinical trials
Also written TD-1473.
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2018 (4)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Janus Kinase Inhibitors source
- One of Protein Kinase Inhibitors source
- One of Tyrosine Kinase Inhibitors source
Studies
Open first, then newest update. How each study uses izencitinib is read from its arms, and is right about nine times in ten.
Testing it · 9
- Efficacy and Safety of TD-1473 in Crohn's DiseaseTerminatedPhase 2Theravance BiopharmaNCT03635112Written as TD-1473
- Efficacy & Safety of TD-1473 in Ulcerative ColitisTerminatedPhase 2/3Theravance BiopharmaNCT03758443Written as TD-1473 Dose A
- TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) StudyTerminatedPhase 2/3Theravance BiopharmaNCT03920254Written as TD-1473 Dose A
- TD-1473 for Active Ulcerative Colitis (UC)CompletedPhase 1Theravance BiopharmaNCT02818686Written as TD-1473
- Single Dose Bioavailability and Ethnobridging PK Study in Healthy SubjectsCompletedPhase 1Theravance BiopharmaNCT04587713Written as TD-1473 [Tablet A]
- SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy SubjectsCompletedPhase 1Theravance BiopharmaNCT02657122Written as TD-1473 for SAD
- Multiple Dose Ethnobridging PK Study in Healthy SubjectsCompletedPhase 1Theravance BiopharmaNCT03750565Written as TD-1473 - Dose A
- Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging StudyCompletedPhase 1Theravance BiopharmaNCT03555617Written as TD-1473
- TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male SubjectsCompletedPhase 1Theravance BiopharmaNCT03408470Written as TD-1473 oral capsule
Codes
What other systems call izencitinib · ClinicalTrials.gg INT001677
- MeSH (NLM) C000718529izencitinibOne source NLM
- UNII (FDA) 2ZT81PV5UMIZENCITINIBConfirmed FDA, NLM
- NCI Thesaurus C175805IzencitinibOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000718529 | izencitinib | One source NLM |
| UNII (FDA) | 2ZT81PV5UM | IZENCITINIB | Confirmed FDA, NLM |
| NCI Thesaurus | C175805 | Izencitinib | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.